Screener
Royalty Pharma RPRX Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Royalty Pharma’s reported figures.
Based on trailing twelve months.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
FAQ
- What is Royalty Pharma's return on invested capital?
- Royalty Pharma (RPRX) reported return on invested capital of 8.7% in Q2 2026.
- How has Royalty Pharma's return on invested capital changed year-over-year?
- Royalty Pharma's return on invested capital decreased by 23.4% year-over-year, from 11.3% to 8.7%.
- What is the long-term trend for Royalty Pharma's return on invested capital?
- Over 4 years (2020 to 2025), Royalty Pharma's return on invested capital has grown at a -7.0% compound annual growth rate (CAGR), from 11.9% to 8.9%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Royalty Pharma's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude